Treats major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). ANDA 77415, held by Impax Labs. Bupropion Hydrochloride.
As of Nov 16, 2026, ANDA 77415 (Bupropion Hydrochloride), held by Impax Labs, was first approved by FDA on Dec 15, 2006, with 19 approved supplements and 0 published complete response letters.
Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient. 1.1 Major Depressive Disorder
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 15, 2006 | Original application | Approved |
| Bupropion Hydrochloride150MG · tablet, extended release;oral | Bupropion Hydrochloride | Discontinued |
| Bupropion Hydrochloride300MG · tablet, extended release;oral | Bupropion Hydrochloride | Discontinued |
| Mar 24, 2025 | Supplement 41Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 38Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 39Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 40Labeling · Standard review | Approved | None posted |
| Aug 7, 2020 | Supplement 36Labeling · Standard review | Approved | None posted |
| Sep 26, 2017 | Supplement 29Labeling · Standard review | Approved | None posted |
| Sep 26, 2017 | Supplement 32Labeling · Standard review | Approved | None posted |
| Sep 26, 2017 | Supplement 33Labeling · Standard review | Approved | None posted |
| Dec 1, 2014 | Supplement 25Labeling · Standard review | Approved | None posted |
| Mar 29, 2012 | Supplement 18Labeling | Approved | |
| Aug 30, 2011 | Supplement 17Labeling | Approved | |
| May 13, 2010 | Supplement 15REMS | Approved | None posted |
| Jan 22, 2010 | Supplement 13Labeling | Approved | None posted |
| Dec 15, 2009 | Supplement 10Labeling | Approved | None posted |
| Nov 26, 2008 | Supplement 6Manufacturing | Approved | None posted |
| Nov 26, 2008 | Supplement 7Labeling | Approved | None posted |
| Jul 10, 2008 | Supplement 5Labeling | Approved | None posted |
| Sep 17, 2007 | Supplement 2Labeling | Approved | None posted |
| Sep 17, 2007 | Supplement 3Labeling | Approved | None posted |
| Dec 15, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters